Halo Neuroscience
The M&A is expected to help Flow expand to treat new mental health conditions that are commonly comorbid with depression.
Yesterday, Dr.
Halo Neuroscience, a device company that develops and sells the Halo Sport neurostimulation headset, announced yesterday that it has secured $13 million in Series B funding.